Newborn Screening for Severe Combined Immunodeficiency: Lessons Learned from Screening and Follow-Up of the Preterm Newborn Population
International Journal of Neonatal Screening · 15.12.2023 · 9 (4) · 68
DOI: 10.3390/ijns9040068 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 15.12.2023. Verfasst von Amy Gaviglio und 4 weiteren Autor:innen. Beteiligte Einrichtung: Association of Public Health Laboratories, Silver Spring, MD 20910, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HRSA HHS, the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS).
Abstract (Originalsprache)
Newborn screening (NBS) for Severe Combined Immunodeficiency (SCID) by measurement of T-cell receptor excision circles (TRECs) successfully identifies newborns with SCID and severe T-cell lymphopenia, as intended. At the same time, NBS programs face the challenge of false positive results, with a disproportionately high number in the premature newborn population. This study evaluates TREC values and SCID screening outcomes in premature newborns and elucidates evidence-based SCID screening practices that reduce unnecessary follow-up activities in this population. De-identified individual SCID newborn screening data and aggregate SCID screening data were obtained from seven states across the US for babies born between 2018 and 2020. Relevant statistics were performed on data pooled from these states to quantify screening performance metrics and clinical impact on various birth and gestational age categories of newborns. The data were normalized using multiples-of-the-median (MoM) values to allow for the aggregation of data across states. The aggregation of NBS data across a range of NBS programs highlighted the trajectory of TREC values over time, both between and within newborns, and provides evidence for improved SCID screening recommendations in the premature and low birth weight population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Association of Public Health Laboratories, Silver Spring, MD 20910, USA.
- Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.
- Wisconsin State Laboratory of Hygiene, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.
- Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.
ORCID-Profile: Michael Lasarev, Mei Baker
Förderung
- HRSA HHS
- the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS)
Zitieren
APA
Gaviglio, A., Lasarev, M., Sheller, R., Singh, S., & Baker, M. (2023). Newborn Screening for Severe Combined Immunodeficiency: Lessons Learned from Screening and Follow-Up of the Preterm Newborn Population. International Journal of Neonatal Screening, 9(4), 68. https://doi.org/10.3390/ijns9040068
Vancouver
Gaviglio A, Lasarev M, Sheller R, Singh S, Baker M. Newborn Screening for Severe Combined Immunodeficiency: Lessons Learned from Screening and Follow-Up of the Preterm Newborn Population. International Journal of Neonatal Screening. 2023;9(4):68. doi:10.3390/ijns9040068
BibTeX
@article{Gaviglio2023,
author = {Gaviglio, Amy and Lasarev, Michael and Sheller, Ruthanne and Singh, Sikha and Baker, Mei},
title = {Newborn Screening for Severe Combined Immunodeficiency: Lessons Learned from Screening and Follow-Up of the Preterm Newborn Population},
journal = {International Journal of Neonatal Screening},
year = {2023},
volume = {9},
number = {4},
pages = {68},
doi = {10.3390/ijns9040068}
}
EUVIMED